Cost-effectiveness analysis of low versus high dose colistin in the treatment of multi-drug resistant pneumonia: a comment

被引:0
|
作者
Effat Davoudi-Monfared
Maryam Taghizadeh-Ghehi
机构
[1] Tehran University of Medical Sciences,Department of Clinical Pharmacy, Faculty of Pharmacy
[2] Tehran University of Medical Sciences,Research Center for Rational Use of Drugs
来源
International Journal of Clinical Pharmacy | 2019年 / 41卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:621 / 622
页数:1
相关论文
共 50 条
  • [41] Cost-Effectiveness Analysis of Oseltamivir for Influenza Treatment Considering the Virus Emerging Resistant to the Drug in Japan
    Nagase, Hiroko
    Moriwaki, Kensuke
    Kamae, Maki
    Yanagisawa, Shinichiro
    Kamae, Isao
    VALUE IN HEALTH, 2009, 12 : S62 - S65
  • [42] COST-EFFECTIVENESS ANALYSIS OF HIGH-DOSE LEVOFLOXACIN THERAPY OF PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA
    Zaytsev, A.
    Makarevich, A.
    VALUE IN HEALTH, 2014, 17 (07) : A596 - A596
  • [43] Analysis of the cost-effectiveness of monotherapy versus fixed dose combination treatment of asthma in Republic of Moldova
    Corlateanu, Alexandru
    Botnaru, Victor
    Procoava, Ana
    Corlateanu, Olga
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [44] COST-EFFECTIVENESS OF DRUG-TREATMENT FOR HIGH BLOOD CHOLESTEROL
    JUNG, P
    GLICK, H
    KINOSIAN, B
    SCHULMAN, K
    JACOBSON, T
    EISENBERG, J
    CLINICAL RESEARCH, 1991, 39 (02): : A412 - A412
  • [45] COST-EFFECTIVENESS OF DRUG-TREATMENT FOR HIGH BLOOD CHOLESTEROL
    GLICK, H
    KINOSIAN, B
    JUHN, P
    SCHULMAN, K
    JACOBSON, T
    EISENBERG, JM
    MEDICAL DECISION MAKING, 1991, 11 (04) : 326 - 326
  • [46] Cost effectiveness of treating multi-drug resistant tuberculosis by adding DeltybaTM to background regimens in Germany
    Diel, Roland
    Hittel, Norbert
    Schaberg, Tom
    RESPIRATORY MEDICINE, 2015, 109 (05) : 632 - 641
  • [47] COST-EFFECTIVENESS ANALYSIS OF IMIQUIMOD VERSUS NO TREATMENT IN ACTINIC KERATOSES
    Walczak, J.
    Nogas, G.
    Dybek-Karpiuk, A.
    Kloc, K.
    Labak, M.
    Pawlik, D.
    VALUE IN HEALTH, 2009, 12 (07) : A456 - A456
  • [48] Cost-Effectiveness Analysis of Surgical versus Medical Treatment of Prolactinomas
    Zygourakis, Corinna C.
    Imber, Brandon S.
    Chen, Rebecca
    Han, Seunggu J.
    Blevins, Lewis
    Molinaro, Annette
    Kahn, James G.
    Aghi, Manish K.
    JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE, 2017, 78 (02) : 125 - 131
  • [49] COST-EFFECTIVENESS ANALYSIS CEFTAZIDIME/AVIBACTAM FOR THE TREATMENT OF HOSPITAL ACQUIRED PNEUMONIA AND VENTILATOR ASSOCIATED PNEUMONIA DUE TO CARBAPENEM RESISTANT KLEBSIELLA PNEUMONIA IN ARGENTINA
    Mac Mullen, M.
    Pein, C.
    VALUE IN HEALTH, 2020, 23 : S551 - S551
  • [50] Cost-effectiveness analysis of low-dose prophylaxis versus on-demand treatment for moderate-to-severe hemophilia A in India
    Seth, Tulika
    Garg, Kapil
    Mandal, Prakas Kumar
    Datta, Anupam
    Verma, Shailendra
    Hanagavadi, Suresh
    Thota, Usha Rani
    HEMATOLOGY, 2023, 28 (01)